［1］Oberaigner W,Minicozzi P,Bielska-Lasota,et al.Survival for ovarian cancer in Europe:the across-country variation did not shrink in the past decade［J］.Acta Oncol,2012,51(4):441-453.
［2］Wang XY,Han FJ,Wu XK,et al.Traditional Chinese medicine (TCM) induced mechanism and research progress of ovarian cancer cell apoptosis［J］.Chin J Integrated And Western Med,2012，32（1）:131-133.［王熙月,韩凤娟,吴效科,等.中药诱导卵巢癌细胞凋亡机制及研究进展［J］.中国中西医结合杂志，2012，32（1）:131-133.］
［3］ Havrilesky LJ,Whitehead CM,Rubatt JM,et al.Evaluation of biomarker panels for early stage ovarian cancer detection andmonitoring for disease recurrence ［J］.Gynecol Oncol,2008,110(3):374-382.
［4］ Cristina A,Filomena MC,Elci IO,et al.A comparison of CA125,HE4,rist ovarian malignancy algorithm(ROMA),and rist malignancy index (RMI) for the classification of ovarian masses ［J］.Clinics,2012,67(5):437-441.
［5］ Zhu ZN,Wei N,Yan NZ.The value of HE4 combined with CA125 in early diagnosis of ovarian cancer［J］.Modern Oncology,2014,22（3）:623-624.［朱振宁，魏娜，严妮子.HE4联合CA125在卵巢癌早期诊断中的应用价值［J］.现代肿瘤医学，2014,22（3）:623-624.］
［6］ Hellstrom I,Raycraft J,Hayden-Ledbetter M,et al.The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma［J］.Cancer Res,2003,63(13):3695-3700.
［7］ Wu XW,Liu LW,He YC,et al.The value of multi-tumor markers protein chip diagnosis system in the differential diagnosis of benign and malignant pleural effusion［J］.Anhui Med and Pharmaceutical J,2009,13（3）:286-288.［吴秀伟，刘利炜，何远春,等.多肿瘤标志物蛋白芯片系统在鉴别良恶性胸腹腔积液中的价值［J］.安徽医药杂志，2009,13（3）:286-288.］
［8］ Guo XX,Duan ML,Du XG,et al.Clinical application of protein chip technology for detecting serum markers ［J］.Chin J Clin Lab Sci,2004，22（3）:224.［郭旭霞，段满乐，杜肖刚，等.蛋白质芯片技术检测肿瘤标志物及临床应用［J］.临床检验杂志，2004，22（3）:224.］
［9］ Gu H,Deng XY,Yan L,et al.Differential diagnostic value of simultaneous determination of tumor marker in ascitic fluid and serum and their ratios for differentiation of benign from malignant ascites ［J］.China J Modern Med,2011,21（14）:1595-1599.［谷欢，邓翔宇，严璐,等.联合检测腹水血清肿瘤标志物及其比值鉴别良恶性腹水的诊断价值［J］.中国现代医学杂志，2011,21（14）:1595-1599.］
［10］ Chen BP,Ling SJ.Value of combined derection of CEA,CA19-9 and 125 in differential diagnosis between benign and malignant ascites［J］.Chin J Clin Gastroenterol,2010，22（4）:208-210.［陈波平，凌书建.CEA,CA199与CA125联合检测对良恶性腹水的鉴别诊断价值［J］.临床消化病杂志，2010，22（4）:208-210.］